Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2005; 11(35): 5525-5529
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5525
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5525
Table 1 Patients’ characteristics. A. Once weekly local IL-2 application. B. Once monthly local IL-2 application
No. | Sex | Primary tumor | Metastases | Neoplastic ascites | Route and dose of IL-2 application | Necrosis induction |
W1 | M | Pancreatic Ca | Liver, abdominal lymph nodes | - | 1.5 MIU i.p. | - |
W2 | F | Stomach Ca | Liver, abdominal lymph nodes | - | 4.5 MIU i.p. | - |
W3 | F | Colorectal Ca | Liver, lung | - | 4.5 MIU i.p.+i.t. | Yes |
W4 | F | Colorectal Ca | Liver, abdominal lymph nodes | - | 4.5 MIU i.t. | Yes |
W5 | M | Colorectal Ca | Peritoneum | + | 1.5 MIU i.p.+i.t. | - |
W6 | F | Ovarian Ca | Lung, peritoneum, spleen | + | 4.5 MIU i.t. | - |
W7 | F | Mammary Ca | Liver, lung, peritoneum | + | 4.5 MIU i.p. | - |
W8 | M | Hemangiosarcoma | Liver, peritoneum, abdominal lymph nodes | +pleural effusion | 4.5 MIU i.p.+i.t. | - |
No. | Sex | Primary tumor | Metastases | Neoplastic ascites | Route of IL-2 application | Necrosis induction |
M1 | M | HCC, liver cirrhosis | - | 4.5/9 MIU i.t. | - | |
M2 | M | HCC, liver cirrhosis | - | 4.5 MIU i.t. | Yes | |
M3 | M | Abdominal mesothelioma | Peritoneum | - | 9 MIU i.t.+i.p. | - |
M4 | F | Colorectal Ca | Liver | - | 9 MIU i.t. | Yes |
M5 | F | Mammary Ca | Liver, bone, skin | – | 1.5 MIU i.t. | - |
M6 | F | Mammary Ca | Liver | - | 4.5/9 MIU i.t. | - |
M7 | M | HCC, liver cirrhosis | - | 4.5 MIU i.t. | Yes |
- Citation: Krastev Z, Koltchakov V, Tomova R, Deredjian S, Alexiev A, Popov D, Tomov B, Koten JW, Jacobs J, Otter WD. Locoregional IL-2 low dose applications for gastrointestinal tumors. World J Gastroenterol 2005; 11(35): 5525-5529
- URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5525.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i35.5525